Search
Search for:
Search for:
Find a Pharmacy
Vertice Login
Menu
About Us
About Us
Our Brand
What We Do
Our People
Contact Us
Careers
FAQ
Workers' Comp Solutions
Workers' Comp Solutions
Pharmacy
Ancillary
Clinical Services
Claims Technology
Claims Technology
Request Demo
Data Analytics
Insights
Insights
RxInformer
Worker's Comprehensive
Clinical Minute
Intelligence
Intelligence
Industry Insights Survey
Industry Insights Survey
2025
2024
2023
2022
2021
2020
2019
Blog
Infographics
Advocacy Compliance
What's Happening
What's Happening
Events
Medmonitor
Social Hub
Customer Center
Customer Center
Pharmacy Search
Ask a Pharmacist
Claims Resources
Claims Resources
Mail Order
Patient Resources
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Tag:
EUA
8 posts found
Medmonitor
FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way
The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.
Read More
Medmonitor
FDA Approves First New Weight Loss Drug Since 2014, Issues EUA for COVID-19 Antibody
Wegovy (semaglutide) and sotrovimab will soon be available.
Read More
COVID-19 Developments
FDA Revokes Emergency Use Authorization for Bamlanivimab for COVID-19
Due to mutating viral strains, the potential benefits of this COVID-19 drug no longer outweigh the risks.
Read More
COVID-19 Developments
FDA Issues EUA for Third COVID-19 Vaccine
The single-dose Janssen vaccine was analyzed in a trial of 39,000 patients.
Read More
Medmonitor
FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments
Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.
Read More
Medmonitor
FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab
Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Read More
COVID-19: Hydroxychloroquine and Remdesivir Updates
The malaria drug loses an EUA for COVID-19, while the FDA warns of drug interactions that can reduce antiviral effectiveness.
Read More
Clinical Insights
Remdesivir a Potential Treatment for COVID-19?
The FDA allows emergency use in response to positive trials, but more research is needed.
Read More
©
2025
Healthesystems
Workers' Comp Property and Casualty PBM
Expires 01/01/2028
info-circle
caret-right
lock
map-marker
magnifier
cross
menu
arrow-right
cross-circle